Literature DB >> 4102028

Value of plasma-lithium monitoring.

D E Fry, V Marks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102028     DOI: 10.1016/s0140-6736(71)92444-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Plasma level studies in psychotropic evaluation.

Authors:  S H Curry
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).

Authors:  E H Bennie; A K Manzoor; A M Scott; G S Fell
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 3.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Letter: Unusual reaction to lithium.

Authors:  J Ananth; R Ruskin
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262

5.  Blood levels and management of lithium treatment.

Authors:  J L Crammer; R M Rosser; G Crane
Journal:  Br Med J       Date:  1974-09-14

6.  Creatine phosphokinase activity during lithium treatment.

Authors:  R Gosling; R J Kerry; G Owen
Journal:  Br Med J       Date:  1972-08-05

7.  Treatment experiences in the lithium clinic at St Thomas Hospital.

Authors:  A J Poole; H D James; W C Hughes
Journal:  J R Soc Med       Date:  1978-12       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.